Point-of-care testing for COVID-19 using SHERLOCK diagnostics
Author:
Joung Julia,Ladha Alim,Saito Makoto,Segel Michael,Bruneau Robert,Huang Mee-li W.,Kim Nam-Gyun,Yu Xu,Li Jonathan,Walker Bruce D.,Greninger Alexander L.,Jerome Keith R.,Gootenberg Jonathan S.,Abudayyeh Omar O.,Zhang Feng
Abstract
AbstractThe recent outbreak of the novel coronavirus SARS-CoV-2, which causes COVID-19, can be diagnosed using RT-qPCR, but inadequate access to reagents and equipment has slowed disease detection and impeded efforts to mitigate viral spread. Alternative approaches based on combinations of isothermal amplification and CRISPR-mediated detection, such as the SHERLOCK (SpecificHighSensitivityEnzymaticReporter UnLOCKing) technique, offer reduced dependence on RT-qPCR equipment, but previously reported methods required multiple fluid handling steps, complicating their deployment outside clinical labs. Here we developed a simple test chemistry called STOP (SHERLOCK Testing in One Pot) for detecting SARS-CoV-2 in one hour that is suitable for point-of-care use. This simplified test, STOPCovid, provides sensitivity comparable to RT-qPCR-based SARS-CoV-2 tests and has a limit of detection of 100 copies of viral genome input in saliva or nasopharyngeal swabs per reaction. Using lateral flow readout, the test returns result in 70 minutes, and using fluorescence readout, the test returns result in 40 minutes. Moreover, we validated STOPCovid using nasopharyngeal swabs from COVID-19 patients and were able to correctly diagnose 12 positive and 5 negative patients out of 3 replicates. We envision that implementation of STOPCovid will significantly aid “test-trace-isolate” efforts, especially in low-resource settings, which will be critical for long-term public health safety and effective reopening of the society.
Publisher
Cold Spring Harbor Laboratory
Reference13 articles.
1. Broughton, J.P. , Deng, X. , Yu, G. , Fasching, C.L. , Servellita, V. , Singh, J. , Miao, X. , Streithorst, J.A. , Granados, A. , Sotomayor-Gonzalez, A. , et al. (2020). CRISPR-Cas12-based detection of SARS-CoV-2. Nat. Biotechnol. 2. Ding, X. , Yin, K. , Li, Z. , and Liu, C. (2020). All-in-One Dual CRISPR-Cas12a (AIOD-CRISPR) Assay: A Case for Rapid, Ultrasensitive and Visual Detection of Novel Coronavirus SARS-CoV-2 and HIV virus. 3. Nucleic acid detection with CRISPR-Cas13a/C2c2 4. Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6 5. Guo, L. , Sun, X. , Wang, X. , Liang, C. , Jiang, H. , Gao, Q. , Dai, M. , Qu, B. , Fang, S. , Mao, Y. , et al. (2020). SARS-CoV-2 detection with CRISPR diagnostics.
Cited by
236 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|